BioHarvest Sciences has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial plant-based compounds, at an industrial scale, without the need to grow the plant itself. Our compositions are both patentable and fingerprint consistent, which solves major roadblocks for both botanical drug and consumer packaged goods product development. These unique and patentable botanical compositions each contain “target optimized” combinations of the phyto-medicinal compounds (with high solubility and bio-availability) found in the original plant. No other company has developed a commercially viable plant cell culture platform at the industrial scale of BioHarvest. Our growth is rapidly accelerating, and our presentation will introduce the R+D breakthroughs accomplished by our team, a quick-paced tour of our near term revenue catalyst, and CEO Ilan Sobel will unveil a new vision for the next growth phase for our platform.